Le Lézard
Classified in: Health, Business
Subject: OTC

MYM Retains Salman Capital Inc. as Financial Advisor to the Company


VANCOUVER, British Columbia, August 21, 2017 /PRNewswire/ --

MYM Nutraceuticals Inc., (CSE: MYM) (OTC: MYMMF) (the "Company" or "MYM") is pleased to announce the appointment of Salman Capital Inc. (SCI) as financial advisor to the Company. SCI will assist the Company in sourcing strategic and joint venture partners and provide MYM with capital markets advice.

About MYM 

MYM Nutraceuticals Inc. is an innovative company focused on acquiring Health Canada licenses to produce and sell high-end organic medicinal cannabis supplements and topical products. To ensure a strong presence and growth potential within the industry, MYM is actively looking to acquire complementary businesses and assets in the technology, nutraceuticals and CBD sectors. MYM shares trade in Canada, Germany and the USA under the following symbols: (CSE: MYM) (OTC: MYMMF) (FRA: 0MY) (DEU: 0MY) (MUN: 0MY) (STU: 0MY).

ON BEHALF OF THE BOARD
Rob Gietl
CEO
MYM Nutraceuticals Inc.
http://www.mymarijuana.ca  

This news release may contain forward-looking statements based on assumptions and judgments of management regarding future events or results. Such statements are subject to a variety of risks and uncertainties which could cause actual events or results to differ materially from those reflected in the forward-looking statements. The company disclaims any intention or obligation to revise or update such statements. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company's Management's Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted on http://www.sedar.com.

This news release does not constitute an offer to sell or solicitation of an offer to buy any of the securities described herein and accordingly undue reliance should not be put on such. Neither the Canadian Securities Exchange (CSE or CNSX Markets), nor its Regulation Services Provider (as that term is defined in policies of the CSE), accepts responsibility for the adequacy or accuracy of this release.

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein in the United States. The securities described herein have not been registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), or any state securities law and may not be offered or sold in the "United States", as such term is defined in Regulation S promulgated under the U.S. Securities Act, unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration requirements is available.


Contact :
MYM Nutraceuticals Inc.
+1-855-696-2261
http://www.mymarijuana.ca


SOURCE MYM Nutraceuticals Inc.


These press releases may also interest you

at 13:30
WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Lifecore Biomedical Inc. f/k/a Landec Corporation resulting from allegations that Lifecore Biomedical may have...

at 13:30
Inland Empire Health Plan (IEHP) held the first of three Maternal Wellness Events on May 9, inviting moms and moms-to-be to its Riverside Community Wellness Center (CWC) to learn the ABCs of motherhood and baby....

at 13:25
Reid's Heritage Homes, a leading real estate home builder in the Greater Golden Horseshoe Region (GHRR) for over 45 years, has unveiled an exciting brand revitalization that reflects its tradition of innovation, quality,...

at 13:16
On the heels of being named Proviso Township Committeeman, Illinois House Speaker Emanuel "Chris" Welch is focusing on building the local party with the launch of the Democratic Party of Proviso....

at 13:15
Warwick Investment Group ("Warwick") is proud to announce its latest strategic investment in a $150 million development agreement in the Delaware Basin in Texas.  "This transaction deploys substantial capital at attractive risk-adjusted returns for...

at 13:15
MarshBerry, a global M&A advisory firm, serving the insurance brokerage and wealth management industries, has released its 2024 Insurance Agency & Brokerage Compensation Review....



News published on and distributed by: